# RegisterNET - A Registry for Neuroendocrine Tumors in the USA and Worldwide

> **NCT02270567** · — · ENROLLING_BY_INVITATION · sponsor: **Wren Laboratories LLC** · enrollment: 400 (estimated)

## Conditions studied

- Neuroendocrine Tumor
- Carcinoid
- Neuroendocrine Carcinoma

## Interventions

- **DEVICE:** NETest

## Key facts

- **NCT ID:** NCT02270567
- **Lead sponsor:** Wren Laboratories LLC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2015-02
- **Primary completion:** 2018-03
- **Final completion:** 2030-12
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2025-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02270567

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02270567, "RegisterNET - A Registry for Neuroendocrine Tumors in the USA and Worldwide". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02270567. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*